FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its second quarter ended June 30, 2007. For the quarter ended June 30, 2007, NovaDel reported a net loss of $5.3 million, or $0.09 cents per share, compared to a net loss of $5.4 million, or $0.09 cents per share, for the previous quarter ended March 31, 2007.
